Pharmaceutical Technology

JANUARY 20, 2023

In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. In 2021, Moderna had a net income of $12.2

Vaccines 98

Vaccines Communication 98

pharmaphorum

DECEMBER 16, 2022

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional, and global life science communications to offer some little tips for enjoying a big business career. Point them to an alternate contact, in case of an emergency during your absence. Emergency cover. Appreciate strong partners.

Communication 96

Communication 96

pharmaphorum

NOVEMBER 27, 2022

There are over 52,000 cases of prostate cancer each year in the UK alone, with over 15,000 new cases of metastatic prostate cancer confirmed annually. reduced risk of death. Its secondary endpoints were time to pain progression and time to first symptomatic skeletal event.

Hospitals 92

Hospitals 92

pharmaphorum

FEBRUARY 28, 2022

As part of SMi’s leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives. Amin Sedighiamiri, Associate Director, Device Development, AstraZeneca. Who should attend?

Packaging 52

Packaging Vaccines Drug Development 52

European Pharmaceutical Review

NOVEMBER 15, 2022

Since their outset the GAMP guides have promoted using a balanced risk-based pragmatism to achieve compliance and the July 2022 release of GAMP 5 second edition strongly encourages the use of critical thinking to support that. The validation of commercially available software applications has largely followed the GAMP V-model.

Documentation 84

Documentation Pharmaceutical Companies Pharmaceutical Companies 84

pharmaphorum

SEPTEMBER 29, 2022

Although mHealth has been gaining in popularity for at least the past decade, before commercializing their mHealth products, developers must determine whether the product is subject to U.S. If so, developers must develop and execute on a regulatory strategy. In these cases, the FDA will exercise enforcement discretion.

Documentation 96

Documentation 96

pharmaphorum

APRIL 11, 2022

Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. VivoSense software is developed specifically for analysis of data from wearable sensors”, explains Tabakin. Searching for the right solution.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Drug Development Packaging 111

European Pharmaceutical Review

NOVEMBER 4, 2022

New approaches to taxane chemotherapies, including the use of orally available formulations with improved pharmacokinetic (PK) profiles compared to IV formulations, have the potential to inject (pun intended) new life into these therapies, offering the improved convenience of at-home pill? Taxanes are derived from the yew tree (genus taxus).

Chemotherapy 81

Chemotherapy Hospitals Packaging 81

Fuld & Company Blog

JANUARY 12, 2023

For the latest and most important 5G news and developments from November and December 2022 please see below for all the key stories. For a PDF version of this news please download here.

Communication 52

Communication 52

pharmaphorum

DECEMBER 5, 2022

Pluvicto becomes the first PSMA-targeted intravenous radioligand therapy – combining a targeting compound or ligand with a therapeutic radionuclide or radioactive particle (in this case, lutetium-177) – to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy.

Chemotherapy 59

Chemotherapy Compounding Labelling Drug Development 59

Pharma in Brief

JANUARY 10, 2024

As you start the new year, allow us to recap 2023’s important legal and regulatory developments for Canadian pharma. The most significant legal development in 2023 was the introduction of a system of patent term adjustment ( PTA ). We also flag what to watch out for in 2024. CADTH launches time-limited recommendations.

Drug Pricing 52

Drug Pricing Documentation Biosimilars Vaccines 52

pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”. million rare disease patients in the U.S.

Pharmaceutical Manufacturing 86

Pharmaceutical Manufacturing 86

The Happy PharmD

JANUARY 13, 2023

With the revolution of Meaningful Use legislation, creating an electronic medication record was mandated by the USA government, thus experts were required to initiate the program. Pharmacy being an integral part of the healthcare system was included in Meaningful Use, and in turn, we saw a boom in the niche industry.

Communication 52

Communication Medical Records Pharmacy Management 52

pharmaphorum

FEBRUARY 16, 2021

With the race for COVID-19 vaccines now in high gear, and drugmakers under increased pressure to develop jabs and supply them in high quantities, the vulnerabilities are becoming more acute. A Reuters report suggests that in this case the intention may have been to sell on the data rather than using it to develop a rival shot.

Vaccines 111

Vaccines Hospitals 111

LifeProNow

MARCH 20, 2023

Nubeqa is already approved in China for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC), who are at high risk of developing metastatic disease. Prostate cancer cases in China have increased significantly in recent years.

Compounding 100

Compounding Pharmaceutical Companies Pharmaceutical Companies 100

European Pharmaceutical Review

DECEMBER 19, 2022

1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. A biosimilar is a biological medicine ‘similar’ to another biological medicine already approved in the EU (the ‘reference medicine’).

Biosimilars 52

Biosimilars 52

pharmaphorum

FEBRUARY 23, 2021

Arist , developers of an innovative enterprise-level text messaging platform for education, training and outreach, has announced that its technology has been optimized to better meet the needs of the life sciences industry. Corporate learning leaders can build courses seven times faster and far more cost-effectively with Arist.

Communication 52

Communication 52

European Pharmaceutical Review

APRIL 21, 2023

5 We considered the whole lifecycle of a drug, as environmental impacts arise at every stage of the process from development and production to administration and disposal. Interestingly, this is not the case for veterinary medicines, where the authorisation can actually be refused if the risk is not adequately mitigated.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceutical Companies Packaging 81

Viseven

JUNE 10, 2022

On the other hand, the dashboard is not something only used by executives – reps and MSLs, too, deserve their portion of clarity. After all, the intention is to facilitate the analysis of any tactical step (or period) – and this sort of control boosts efficiency in a variety of cases. 1 Use case demand analysis, a.k.a.

Communication 52

Communication 52

FDA Law Blog: Biosimilars

MARCH 13, 2024

This blogger’s 11th grade math teacher, Mr. Neilitz, used to tell a riddle that he associated with an easy-to-answer math problem: “Who’s buried in Grant’s Tomb?” After all, it never invested the time and resources necessary to obtain approval for commercial marketing or use. Part 3: Who’s Buried in Grant’s Tomb? Appendix D.

Documentation 59

Documentation Drug Development 59

PharmaState Academy

JULY 23, 2023

Consider how your brand, product or service makes a difference in the lives of the person who is using it. I remember what Pramod Sapre told us about Colimex Drops when it was introduced. he said, “tell doctors Colimex was developed to bring smiles in mothers and the infants who have terrible colic pain.

Packaging 52

Packaging 52

European Pharmaceutical Review

JULY 13, 2022

T-cell technologies, we are focused on the use of our platform allogeneic ?? Our work is establishing whether it is possible to use allogeneic innate immune cells from a healthy donor to support the immune system of a person with cancer in combatting the condition. For what indications are gamma delta T cells being developed?

Immunity 78

Immunity Immunization Chemotherapy 78

The Thyroid Pharmacist

JULY 14, 2023

2] In some cases, the person will become hyperthyroid, and the dosage of their medications will need to be reduced. In other cases, individuals may find that the thyroid hormones become “built into” their physiology, and that the presence of the external hormones will suppress their internal thyroid hormone production.

Dosage 97

Dosage Immunity Immunization Documentation 97

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences. Yet it is widely mistrusted.

Vaccines 119

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 119

Express Pharma

AUGUST 16, 2023

Technology and production capacity are concentrated in high-income countries and in the hands of a few pharmaceutical corporations. High-income countries (HICs), including the US, UK, Switzerland, and many EU countries, tied up most of the global supply of vaccine doses early on in the epidemic. But there are some positive aspects.

Vaccines 79

Vaccines Compounding 79

pharmaphorum

DECEMBER 22, 2021

Creating certainty in a landscape still convulsed by the pandemic is a lofty ambition, but pharma companies can use the disruption to develop positive internal change, as well as shoring up sales. By using simple technology to practice you can see how those crafted marketing plans sound. About 60 Seconds.

Communication 52

Communication 52

pharmaphorum

MAY 5, 2022

It is a great mindset as it helps employees see where their strengths are and how they can develop their careers.”. It also advocates for the regular use of remote digital coaching to strengthen performance in an ever increasingly competitive sales landscape where time with HCPs has become limited. About 60 Seconds.

Communication 52

Communication Hospitals 52

Pharmaceutical Technology

OCTOBER 13, 2022

Based in Colleretto Giacosa, Italy, AorticLab’s innovative embolic protection device ‘Flower’ uses exclusive ‘Catch & Flow’ technology which combines cutting-edge design with an ultra-fine mesh. Using this device, we can capture more debris for two different reasons. One, is the characteristic of the filter fabric.

Hospitals 52

Hospitals 52

pharmaphorum

OCTOBER 5, 2021

Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of a new healthcare landscape, says Debiopharm Innovation Fund’s Tanja Dowe. We already have wearables that can conduct in-depth analysis on e.g. our heart health, and development doesn’t stop there.

Hospitals 129

Hospitals Documentation Diabetes Communication 129

PharmaShots

APRIL 10, 2023

It constitutes 5 to 10 percent of all diabetes cases Type 2 Diabetes Mellitus (T2DM): Accounting for 90-95 percent of diabetes mellitus cases, type 2 diabetes is characterized by less insulin secretion or the inability of the body’s cells to respond to insulin. How Insulin Deficit Develops Diabetes?

Diabetes 40

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 1, 2022

Corporate acquisitions like these are not uncommon, but someone at the United States Department of Justice took notice of this announcement. HIPAA does not specifically prohibit using and sharing open protocol-based software. As the case study of Plaid makes clear, the time for the industry to embrace open protocol is now.

HIPAA 98

HIPAA Insurance Coverage and Processing Specialty Pharmacies Communication 98

Pharmaceutical Technology

NOVEMBER 2, 2022

Being able to address medical communities on multiple channels challenges the paradigm of the very rigid structure we are used to in medical affairs,” starts Ødum. In the endeavour to tackle the gaps in patient care, worldwide collaboration between the corporate pharma world and the medical community is essential.

Communication 52

Communication Drug Development 52

pharmaphorum

AUGUST 13, 2020

Pfizer has shown remarkable emotional intelligence at a corporate brand level”. million to small businesses to support the Local Initiatives Support Corporation and has offered special prices for nurses and teachers. Pfizer has shown remarkable emotional intelligence at a corporate brand level. Verizon also donated $2.5

Health and Personal Care Stores 92

Health and Personal Care Stores Vaccines Communication Diabetes 92

Pharmaceutical Technology

OCTOBER 5, 2022

Technology is advancing the possibilities of healthcare treatments, from the development of innovative new drugs to freeing up time for doctors thanks to monitoring devices for patients with conditions such as diabetes and high blood pressure. However, this is not typically the case in the UK health and pharma segments.

Compounding 52

Compounding Diabetes 52

pharmaphorum

DECEMBER 1, 2020

Patients with the worst cases of periodontal disease are more likely to have prediabetes or diabetes. The study found that using a FINDRISC (FINnish Diabetes Risk Score) questionnaire completed by each patient alone detected undiagnosed hyperglycemia with 87% accuracy. PR and Corporate Communications Specialist. www.sunstar.com.

Diabetes 52

Diabetes Communication 52

pharmaphorum

DECEMBER 2, 2020

Both in their mid-twenties, the two men set up what was initially a fine chemicals business in a Brooklyn factory, using a loan from Pfizer’s father as capital. It was a success, and set the pattern for the company’s future development. Under his stewardship, Pfizer’s expertise in scientific production methods developed greatly.

Compounding 128

Compounding Vaccines Biosimilars Diabetes 128

Pharmaceutical Technology

FEBRUARY 8, 2023

In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases. This document delved into aspects related to manufacturing, preclinical, and clinical trial design for all phases of clinical development.

Documentation 105

Documentation Drug Development Communication 105